A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1
Clinical Trials Related to Mantle Cell Lymphoma
Related studies linked through entity extraction aliases.
A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Abexinostat and Ibrutinib in Diffuse Large B-cell Lymphoma and Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Carfilzomib + Lenalidomide and Dexamethasone for BTK Inhibitors Relapsed-refractory or Intolerant MCL
- Status
- UNKNOWN
- Phase
- PHASE2
Bendamustine, Obinutuzumab, and Venetoclax in Patients With Untreated Mantle Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Acalabrutinib-Lenalidomide-Rituximab in Patients With Untreated MCL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
BTK Inhibitor DTRMWXHS-12 in Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Study of Bendamustine and Rituximab Plus Venetoclax in Untreated Mantle Cell Lymphoma Over 60 Years of Age
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Hematologic Malignancies (MK-2140-001)
- Status
- COMPLETED
- Phase
- PHASE1
A Disease Registry of Patients With Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- N/A
A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ibrutinib, Rituximab, Venetoclax, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Safety and Antitumor Activity Study of Loncastuximab Tesirine and Durvalumab in Diffuse Large B-Cell, Mantle Cell, or Follicular Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Safety and Efficacy Study of Loncastuximab Tesirine + Ibrutinib in Diffuse Large B-Cell or Mantle Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Chi-BEAC Combining With Auto-HSCT to Treat Aggressive Lymphoma Subjects
- Status
- UNKNOWN
- Phase
- PHASE2
Acalabrutinib With Bendamustine / Rituximab Followed by Cytarabine / Rituximab for Untreated Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2